Aurinia Pharmaceuticals Inc.·4

Feb 22, 4:27 PM ET

Miller Joseph M 4

4 · Aurinia Pharmaceuticals Inc. · Filed Feb 22, 2024

Insider Transaction Report

Form 4
Period: 2024-02-20
Miller Joseph M
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2024-02-20+196,153530,739 total
Footnotes (2)
  • [F1]Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date.
  • [F2]Includes shares of common stock acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 1,732 shares of common stock were acquired on May 31, 2023 and 1,742 shares of common stock were acquired on November 30, 2023.

Documents

1 file
  • 4
    wk-form4_1708637259.xmlPrimary

    FORM 4